Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Microbial Pathogenesis|February 24, 2018
Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against itAli Mirhoseini, Jafar Amani, Shahram Nazarian
Iranian Journal of Immunology : IJI|March 18, 2018
Production of Chicken Egg Yolk Antibody (IgY) Against Recombinant Cholera Toxin B Subunit and Evaluation of Its Prophylaxis Potency in MiceBabak Barati, Firouz Ebrahimi, Shahram Nazarian
Microbial Pathogenesis|December 29, 2022
Bioinformatics design of recombinant chimeric protein containing SipD and LptD immunogens and evaluation of its immunogenicity against Salmonella TyphimuriumSeyed Mojtaba Aghaie, Mohammad Tabatabaei, Shahram Nazarian
Molecular Immunology|September 23, 2019
Entrapment of HETS recombinant protein onto PLGA and alginate NPs improves the immunogenicity of the protein against E. coli O157:H7Emad Kordbacheh, Shahram Nazarian, Abbas Hajizade, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 21, 2018
Entrapment of LTB protein in alginate nanoparticles protects against Enterotoxigenic Escherichia coliEmad Kordbacheh, Shahram Nazarian, Abbas Hajizadeh, et al.
Avicenna Journal of Medical Biotechnology|September 5, 2022
An in silico Design, Expression and Purification of a Chimeric Protein as an Immunogen Candidate Consisting of IpaD, StxB, and TolC Proteins from Shigella sppJavad Fathi, Shahram Nazarian, Emad Kordbacheh, et al.
Iranian Journal of Basic Medical Sciences|June 21, 2018
An LTB-entrapped protein in PLGA nanoparticles preserves against enterotoxin of enterotoxigenic Escherichia coliEmad Kordbacheh, Shahram Nazarian, Davoud Sadeghi, et al.
Microbial Pathogenesis|July 5, 2016
In vivo validation of the immunogenicity of recombinant Baumannii Acinetobactin Utilization A protein (rBauA)Hamid Esmaeilkhani, Iraj Rasooli, Shahram Nazarian, et al.
Microbial Pathogenesis|January 11, 2024
Expression and purification of TolC as a recombinant protein vaccine against Shigella flexneri and evaluation of immunogenic response in miceRazieh Veisi, Shahram Nazarian, Javad Fathi, et al.
International Immunopharmacology|November 30, 2022
In silico design, production and immunization evaluation of a recombinant bivalent fusion protein candidate vaccine against E. coli O157:H7Hossein Samiei, Shahram Nazarian, Abass Hajizade, et al.
Pageof 8